Live feed07:31:19·484dSECFilingvia QuantisnowKiniksa Pharmaceuticals International plc filed SEC Form 8-K: Termination of a Material Definitive Agreement, Results of Operations and Financial Condition, Costs Associated with Exit or Disposal Activities, Financial Statements and ExhibitsByQuantisnow·Wall Street's wire, on your screen.KNSA· Kiniksa Pharmaceuticals International plcHealth CareOriginal source
